Literature DB >> 27237114

HIV and COPD: a conspiracy of risk factors.

Umesh G Lalloo1, Sandy Pillay2, Rosie Mngqibisa2, Sabeer Abdool-Gaffar3, Anish Ambaram4.   

Abstract

Chronic obstructive pulmonary disease (COPD) is an under recognized complication of HIV infection. It is estimated that up to 25% of HIV infected people may have COPD. HIV is associated with COPD as a result of a complex interplay of multiple factors such as pulmonary inflammation, recurrent pulmonary infections especially tuberculosis (TB), increased cigarette smoking, socio-economic status, childhood respiratory illnesses and industrial and environmental exposures; each of which are risk factors for COPD in their own right. COPD presents at an earlier age in people with HIV infection. There are over 35 million people living with HIV, and most people infected with HIV live in developing regions of the world where they are faced with multiple risk factors for COPD and suboptimal access to health care. TB is the commonest infectious complication of HIV, and HIV infected persons often experience multiple episodes of TB. Cigarette smoking is increasing in developing countries where the greatest burden of TB and HIV is experienced. Cigarette smoking is associated with increased risk of TB and may be associated with acquisition of HIV infection and progression. It is not clear whether non-infectious pulmonary inflammation persists in the lung when immune reconstitution occurs. Prevention and control of HIV infection must be part of the multiple interventions to reduce the global burden of COPD. A multidisciplinary approach, including behavioural science is required to address this challenge. It presents research opportunities that should be driven by the pulmonology community.
© 2016 Asian Pacific Society of Respirology.

Entities:  

Keywords:  chronic obstructive pulmonary disease; human immunodeficiency virus; infections; smoking; tuberculosis

Mesh:

Year:  2016        PMID: 27237114     DOI: 10.1111/resp.12806

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  7 in total

1.  Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV.

Authors:  Matthew Triplette; Amy Justice; Engi F Attia; Janet Tate; Sheldon T Brown; Matthew Bidwell Goetz; Joon W Kim; Maria C Rodriguez-Barradas; Guy W Soo Hoo; Cherry Wongtrakool; Kathleen Akgün; Kristina Crothers
Journal:  AIDS       Date:  2018-02-20       Impact factor: 4.177

2.  Urban-Rural Disparities in Chronic Obstructive Pulmonary Disease Management and Access in Uganda.

Authors:  Nicole M Robertson; Emily M Nagourney; Suzanne L Pollard; Trishul Siddharthan; Robert Kalyesubula; Pamela J Surkan; John R Hurst; William Checkley; Bruce J Kirenga
Journal:  Chronic Obstr Pulm Dis       Date:  2019-01-04

3.  The synthesis, biological evaluation and structure-activity relationship of 2-phenylaminomethylene-cyclohexane-1,3-diones as specific anti-tuberculosis agents.

Authors:  Muzafar Ahmad Rather; Ali Mohd Lone; Bisma Teli; Zubair Shanib Bhat; Paramjeet Singh; Mubashir Maqbool; Bashir Ahmad Shairgojray; Mohd Jamal Dar; Shajrul Amin; Syed Khalid Yousuf; Bilal A Bhat; Zahoor Ahmad
Journal:  Medchemcomm       Date:  2017-10-13       Impact factor: 3.597

Review 4.  A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science.

Authors:  Allison R Webel; Julie Schexnayder; Patricia A Cioe; Julie A Zuñiga
Journal:  J Assoc Nurses AIDS Care       Date:  2021 May-Jun 01       Impact factor: 1.809

5.  Epidemiology of chronic obstructive pulmonary disease in the global HIV-infected population: a systematic review and meta-analysis protocol.

Authors:  Jean Joel R Bigna; Angeladine Malaha Kenne; Serra Lem Asangbeh
Journal:  Syst Rev       Date:  2017-03-29

6.  Etiology of Respiratory Complications among Iranian HIV Infected Patients.

Authors:  Majid Marjani; Mahtab Moeinpour; Afshin Moniri; Shadi Khabiri; Seyed Mohammadreza Hashemian; Payam Tabarsi; Ali Akbar Velayati
Journal:  Tanaffos       Date:  2019-02

Review 7.  Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection.

Authors:  Yulia Alexandrova; Cecilia T Costiniuk; Mohammad-Ali Jenabian
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.